Literature DB >> 18380641

Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ.

Carolyn McMillan1, Clare Bradley, Salman Razvi, Jolanta Weaver.   

Abstract

OBJECTIVES: This article reports the psychometric properties of two new condition-specific questionnaires: 1) the 18-item Underactive Thyroid-Dependent Quality of Life Questionnaire (ThyDQoL) individualized measure of perceived impact of hypothyroidism on quality of life (QoL); and 2) the 15-item Underactive Thyroid Symptom Rating Questionnaire (ThySRQ), in which patients rate symptom bother.
METHODS: A cross-sectional survey was conducted of 110 adults with overt and subclinical hypothyroidism, 103 treated with thyroxine. Patients, the majority of whom (81%) were women, were recruited from primary care (57%) and from hospital clinics (43%). The mean age of patients was 55.1 (SD 14.3) years. Respondents rated personally applicable ThyDQoL life domains for importance and impact of hypothyroidism, and ThySRQ symptom bother.
RESULTS: Completion rates were high (>98%). All 18 ThyDQoL domains were rated as negatively impacted by hypothyroidism and important for QoL. The ThyDQoL had high internal consistency reliability (Cronbach's alpha = 0.949 [N = 97]), factor analysis indicated that applicable domains could be combined into an overall Average Weighted Impact score, for which the sample mean, -3.11 (2.2), showed considerable negative impact of hypothyroidism on QoL (maximum possible range -9 to +3). There is good preliminary evidence to justify shortening the ThyDQoL to 14 domain-specific items. For the ThySRQ Cronbach's alpha was 0.808 (N = 95). Highest symptom bother ratings were for hair problems, weight gain, depression, cold, and tiredness.
CONCLUSIONS: Both the ThyDQoL and ThySRQ are highly acceptable to patients with hypothyroidism and have good internal consistency reliability. Their sensitivity to change now needs to be evaluated in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18380641     DOI: 10.1111/j.1524-4733.2007.00232.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  23 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study.

Authors:  Anjali Mishra; Mayilvaganan Sabaretnam; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

4.  The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study.

Authors:  Gregorio Scerrino; Giuseppina Melfa; Cristina Raspanti; Andrea Attard; Sergio Mazzola; Roberto Gullo; Sebastiano Bonventre; Marco Attard; Gianfranco Cocorullo; Gaspare Gulotta
Journal:  Langenbecks Arch Surg       Date:  2017-03-15       Impact factor: 3.445

5.  Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1).

Authors:  Salman Razvi; Vicky Ryan; Lorna Ingoe; Simon H Pearce; Scott Wilkes
Journal:  Eur Thyroid J       Date:  2019-11-21

6.  How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study.

Authors:  F Vaisman; C Medina Coeli; L S Ward; H Graf; G Carvalho; R Montenegro; M Vaisman
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

7.  Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study.

Authors:  Patrícia dos Santos Vigário; Fernanda Vaisman; Cláudia Medina Coeli; Laura Ward; Hans Graf; Gisah Carvalho; Renan Montenegro Júnior; Mário Vaisman
Journal:  Endocrine       Date:  2013-01-31       Impact factor: 3.633

8.  Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO.

Authors:  Torquil Watt; Giuseppe Barbesino; Jakob Bue Bjorner; Steen Joop Bonnema; Branka Bukvic; Russell Drummond; Mogens Groenvold; Laszlo Hegedüs; Valeska Kantzer; Kathryn E Lasch; Claudio Marcocci; Anjali Mishra; Romana Netea-Maier; Merel Ekker; Ivan Paunovic; Terence J Quinn; Åse Krogh Rasmussen; Audrey Russell; Mayilvaganan Sabaretnam; Johannes Smit; Ove Törring; Vladan Zivaljevic; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2014-09-07       Impact factor: 4.147

9.  Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED): protocol for a mixed methods feasibility study to assess the clinical utility of lower dose thyroxine in elderly hypothyroid patients: study protocol for a randomized controlled trial.

Authors:  Scott Wilkes; Simon Pearce; Vicky Ryan; Tim Rapley; Lorna Ingoe; Salman Razvi
Journal:  Trials       Date:  2013-03-22       Impact factor: 2.279

10.  The effect of substitution therapy on symptoms in patients with hypothyroidism following treatment for laryngeal and hypopharyngeal carcinomas.

Authors:  A M Lo Galbo; I M Verdonck-De Leeuw; P Lips; D J Kuik; C R Leemans; R De Bree
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.